Newly discovered role for enzyme in neurodegenerative diseases

	Tweet

Neurodegenerative diseases like Alzheimer’s and Parkinson’s are partly attributable to brain inflammation. Researchers at Karolinska Institutet now demonstrate in a paper published in Nature that a well-known family of enzymes can prevent the inflammation and thus constitute a potential target for drugs.

Research suggests that microglial cells - the nerve system’s primary immune cells - play a critical part in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. The over-activation of these cells in the brain can cause inflammation, resulting in neuronal death.

Scientists at Karolinska Institutet and Seville University, working in collaboration with colleagues at Lund University, have now found a way to prevent the activation of the microglia and consequently the inflammation they cause. The key is the blocking of enzymes called caspases, which the team has shown control microglial activation

"The caspases are a group of enzymes known for causing cell death,” says Associate Professor Bertrand Joseph, who headed the study. “That they also serve as signal molecules that govern that activity of other cells was an unexpected discovery that gives them an entirely new physiological role.”

By studying cell cultures and mice, the researchers show that certain caspases (3, 7 and 8) activate rather than kill microglial cells, which triggers an inflammatory reaction. Mice given caspase inhibitors displayed fewer activated microglia and less inflammation and cell death in the surrounding neurons.

They also examined samples from deceased Alzheimer’s and Parkinson’s patients and discovered a higher incidence of activated caspases in their microglial cells.

“We’ll now be examining whether the substances that inhibit the caspases can be candidates for useful drugs in the treatment of certain neurological diseases,” says Dr Joseph.

Publication:

Miguel A. Burguillos, Tomas Deierborg, Edel Kavanagh, Annette Persson, Nabil Hajji, Albert Garcia-Quintanilla, Josefina Cano, Patrik Brundin, Elisabet Englund, Jose L. Venero & Bertrand Joseph
Caspase signaling controls microglia activation and neurotoxicity

Nature, AOP 9 March 2011, doi:10.1038/nature09788.

###

Associate Professor
Bertrand Joseph

Work +46 (0)8 517 73 826
Mobile +46 (0)73 706 7110

E-mail:

RELATED STORIES:
Sleep loss may rev up appetite   MRI may predict continued decline in patients with mild cognitive impairment   Hormone replacement therapy tied to mental benefits   Mothers of children with autism have higher parental stress, psychological distress   Waking up memories while you sleep   Training helps people with Parkinson’s avoid falls   Dopamine limits learning in Parkinson’s patients   Alzheimer Patients Treated With Testosterone Show Improved Quality of Life   Combining brain imaging, genetic analysis may help identify people at early risk of Alzheimer’s   Brain enzyme links diabetes to Alzheimer’s   Improved method of electrical stimulation could help treat damaged nerves   Mini-stroke seen as urgent warning of major stroke

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]